Show simple item record

dc.contributor.authorAthauda, A
dc.contributor.authorNankivell, MG
dc.contributor.authorLangley, RE
dc.contributor.authorAlderson, D
dc.contributor.authorAllum, WH
dc.contributor.authorGrabsch, HI
dc.contributor.authorChau, I
dc.contributor.authorStarling, N
dc.contributor.authorFalk, S
dc.contributor.authorCrellin, A
dc.contributor.authorMansoor, Was
dc.contributor.authorCoxon, F
dc.contributor.authorDarby, S
dc.contributor.authorThompson, J
dc.contributor.authorCummins, SJ
dc.contributor.authorBeaumont, E
dc.contributor.authorWest, N
dc.contributor.authorLanger, R
dc.contributor.authorPritchard, S
dc.contributor.authorCunningham, D
dc.date.accessioned2019-11-19T16:01:03Z
dc.date.available2019-11-19T16:01:03Z
dc.date.issued2019en
dc.identifier.citationAthauda A, Nankivell MG, Langley RE, Alderson D, Allum WH, Grabsch HI, et al. Impact of age and sex on chemotherapy (CTx) efficacy, toxicity and survival in early oesophagogastric (OG) cancer: a pooled analysis of 3265 patients from four large randomised trials (OE02, OE05, MAGIC & ST03). J Clin Oncol. 2019;37(15_suppl):4022-.en
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.4022en
dc.identifier.urihttp://hdl.handle.net/10541/622436
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2019.37.15_suppl.4022en
dc.titleImpact of age and sex on chemotherapy (CTx) efficacy, toxicity and survival in early oesophagogastric (OG) cancer: a pooled analysis of 3265 patients from four large randomised trials (OE02, OE05, MAGIC & ST03)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Royal Marsden Hospital, Surreyen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record